This case report highlights the risk of sudden cardiac death in familial ballooning posterior mitral leaflet syndrome (mitral valve prolapse) and the failure of propranolol or Dilantin to prevent fatal arrhythmias or correct Q-Tc prolongation.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to sudden death risk in familial mitral valve prolapse with QTc prolongation; leaves open effective preventive strategies.
The propositus, one of six family members with the ballooning posterior mitral leaflet syndrome, had experienced five syncopal episodes prior to initial presentation with cardiac arrest. Subsequent evaluation, after nearly complete recovery, revealed slight Q-Tc prolongation but no arrhythmia, despite extensive ECG monitoring and maximum exercise testing. Intravenous propranolol failed to alter the Q-Tc interval or the magnitude of ballooning of the posterior mitral leaflet at cardiac catheterization. Therapy with oral Dilantin to the point of clinical toxicity failed to significantly shorten the Q-Tc interval. While on oral propranolol, the patient, during a stressful argument, suffered her final cardiac arrest. Detailed post mortem studies were performed, with histochemical identification of the "myxomatous" material not previously reported.
No takes yet. Share an insight, caveat, or question.
Shappell et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: